Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2022 | Racial disparities affecting black patients with diffuse large B-cell lymphoma

Daniel Arthur Ermann, MD, Huntsman Cancer Institute, University of Utah, UT, talks on evaluating the influence of racial identity on the most common subtype of non-Hodgkin lymphoma, diffuse large B-cell lymphoma (DLBCL) using The National Cancer Database. Of 223,709 patients with DLBCL, 87% were white, 8% were Black, and 5% were other. Multivariate analysis demonstrated Black race was independently associated with worse overall survival (OS) compared to white. However, this disparity in OS became insignificant when patients were matched in surrogate markers of healthcare access. The study warrants further investigation into racial differences to optimize care for all patients with DLBCL. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.